Fei Wang
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 2%
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- Extracellular vesicles in disease
Papers in
-
- Circular RNAs in diseases 34
- RNA modifications and cancer 28
- RNA Research and Splicing 13
-
- Cancer-related molecular mechanisms research 66
- MicroRNA in disease regulation 45
- Co-authors
- Jia Xiao (10 shared papers)Hua Wang (7 shared papers)Kwok‐Fai So (5 shared papers)Yingxia Liu (4 shared papers)Nai-Kei Wong (3 shared papers)Wei Li (3 shared papers)Kazuo Koike (2 shared papers)Xiaowei Liu (2 shared papers)
- Journals
- PLoS ONE (7 papers)Scientific Reports (6 papers)Biomedicine & Pharmacotherapy (5 papers)Biochemical and Biophysical Research Communications (5 papers)Journal of Clinical Oncology (4 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Fei Wang
302 papers receiving 6.8k citations
Fei Wang's Hit Papers
Peers
Comparison fields: 5 of 164
- Cancer Research 2.1k
- Molecular Biology 3.0k
- Developmental Neuroscience 164
- Pathology and Forensic Medicine 566
- Hepatology 221
Countries citing papers authored by Fei Wang
This map shows the geographic impact of Fei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Wang more than expected).
Fields of papers citing papers by Fei Wang
This network shows the impact of papers produced by Fei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Wang. The network helps show where Fei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 316 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global liver disease burdens and research trends: Analysis from a Chinese perspective Hit paper breakdown → | 2019 | 427 |
| 2 | 2013 | 212 | |
| 3 | 2018 | 153 | |
| 4 | 2019 | 130 | |
| 5 | 2011 | 130 | |
| 6 | 2014 | 119 | |
| 7 | 2015 | 111 | |
| 8 | 2017 | 109 | |
| 9 | 2014 | 107 | |
| 10 | 2022 | 98 | |
| 11 | 2018 | 93 | |
| 12 | 2011 | 92 | |
| 13 | 2015 | 84 | |
| 14 | 2017 | 83 | |
| 15 | 2022 | 78 | |
| 16 | 2022 | 78 | |
| 17 | 2016 | 74 | |
| 18 | 2013 | 74 | |
| 19 | 2017 | 72 | |
| 20 | Serum microRNA-499 and microRNA-208a as biomarkers of acute myocardial infarction. | 2014 | 69 |
About Fei Wang
Fei Wang is a scholar working on Molecular Biology, Cancer Research, Epidemiology, Genetics and Pathology and Forensic Medicine, having authored 316 papers that have together received 6.8k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (66 papers), MicroRNA in disease regulation (45 papers), Circular RNAs in diseases (34 papers), RNA modifications and cancer (28 papers), Mesenchymal stem cell research (21 papers), Liver Disease Diagnosis and Treatment (14 papers), RNA Research and Splicing (13 papers) and Glioma Diagnosis and Treatment (9 papers). The work is most often cited by research in Cancer Research (2.1k citations), Molecular Biology (3.0k citations), Developmental Neuroscience (164 citations), Pathology and Forensic Medicine (566 citations) and Hepatology (221 citations). Fei Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Jia Xiao, Hua Wang, Kwok‐Fai So, Yingxia Liu, Nai-Kei Wong, Wei Li, Kazuo Koike, Xiaowei Liu, Jiyan Ma and Cui Li. Their work appears in journals such as PLoS ONE, Scientific Reports, Biomedicine & Pharmacotherapy, Biochemical and Biophysical Research Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.